Obermatt
See Similar Stocks →

Tenax Therapeutics

NAQ:TENX · US88032L6056
BiotechnologyX-Small

360° View

no current rank
Price/Sales—
Price/Earnings61
Price/Book41
Dividend Yield—
Revenue Growth—
Profit Growth71
Capital Growth88
TSR 52w77
Leverage36
Liquidity16
Refinancing65
Combined—
Analyst Opinions73
Pro Holdings31
Opinion Changes50
Market Pulse16

Profile

CountryUSA
IndustryBiotechnology
SizeX-Small
TypePublic Company
ExchangeNASDAQCM
Founded2008
Employees17
Websitetenaxthera.com
ISINUS88032L6056
Last UpdateApr 2, 2026
Index & Theme
CardiovascularChronic DiseasesPulmonologyOncologyBiotechnologyHealth CareTherapeutics

Description

Tenax Therapeutics, Inc., a clinical-stage pharmaceutical company that develops novel cardiopulmonary therapies. The company employs a clinician-focused drug development approach, led by key opinion leaders and heart failure experts, and informed by…

Similar Stocks

The companies this stock is ranked against.

Compare Tenax Therapeutics with its peers
Cytokinetics
NSQ:CYTK
13
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Tectonic Therapeutic
NMQ:TECX
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Spero Therapeutics
NSQ:SPRO
77
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Aclaris Therapeutics
NSQ:ACRS
28
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Tonix Pharmaceuticals
NAQ:TNXP
37
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Esperion Therapeutics
NMQ:ESPR
9
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →